Home/Revalesio/Bert van den Bergh

BV

Bert van den Bergh

Executive Chairman of the Board

Therapeutic Areas

Neurology Aging

Revalesio Pipeline

Drug	Indication	Phase
RNS60	Ischemic Stroke Recovery	Phase 2

Leadership Team at Revalesio

Greg Archambeau

Jordan Dubow, MD

Chief Medical Officer

Executive Business Advisor

Vice President of Finance

View full Revalesio profile